Standout Papers
Immediate Impact
69 standout
Citing Papers
Lipoprotein(a) and cardiovascular disease
2024 Standout
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
Works of Sarah Hanson being referenced
Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses
2013 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Sarah Hanson | 193 | 692 | 449 | 601 | 57 | 2.0k | |
| Nicholas Buys | 545 | 398 | 517 | 367 | 132 | 2.9k | |
| Ehab S. Eshak | 161 | 485 | 306 | 369 | 103 | 1.5k | |
| Amanda Patterson | 454 | 1084 | 658 | 378 | 96 | 2.5k | |
| Bernard Favrat | 245 | 216 | 285 | 155 | 141 | 2.7k | |
| Reem Malouf | 288 | 497 | 428 | 170 | 59 | 3.1k | |
| Cem Ekmekçioğlu | 163 | 398 | 550 | 638 | 98 | 3.1k | |
| Jacob Plange‐Rhule | 406 | 768 | 535 | 365 | 88 | 2.9k | |
| Ai Zhao | 185 | 612 | 285 | 696 | 139 | 2.0k | |
| Pamela I. Clark | 356 | 434 | 1130 | 135 | 65 | 2.3k | |
| Hossein Yarandi | 505 | 475 | 346 | 130 | 118 | 2.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...